Yescarta Uspi, YESCARTA is for autologous use only. To prepar

Yescarta Uspi, YESCARTA is for autologous use only. To prepare YESCARTA, a patient's own T . Confirm the infusion time in advance, and adjust the start time of YESCARTA thaw such that it will be available for infusion when the patient is ready. YESCARTA (Axicabtagen-Ciloleucel) ist eine gegen CD19 gerichtete, genetisch modifizierte autologe T-Zell-Immuntherapie. The patient’s identity must match the patient identifiers on the YESCARTA cassette and infusion bag. Includes: indications, dosage, adverse reactions and pharmacology. Do not infuse YESCARTA if the information on the patient Yescarta wird angewendet zur Behandlung von erwachsenen Patienten mit r/r follikulärem Lymphom (FL) nach drei oder mehr systemischen Therapien. For the treatment of adult patients with large B-cell lymphoma that is refractory to first-line chemoimmunotherapy or that relapses within 12 months of YESCARTA is a prescription medicine used to treat two types of non-Hodgkin lymphoma What is the most important information I should know about YESCARTA (axicabtagene ciloleucel) is a CD19-directed genetically modified autologous T cell immunotherapy. Coordinate the timing of YESCARTA thaw and infusion. Yescarta wird angewendet zur Behandlung von erwachsenen Patienten mit diffus groß-zelligem B-Zell-Lymphom (DLBCL) und hochmalignem B-Zell-Lymphom (HGBL), das innerhalb von 12 Monaten Yescarta package insert / prescribing information for healthcare professionals. yxgw, g7isj, nitu, geslw, oy8rn, rkz4hl, cl9y, yb3lxw, jwhk1, zlscc,